Pharmafile Logo
Pharmafocus logo
Advanced Search

Skyepharma

Showing 6 posts of 6 posts found.

asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …

News

SkyePharma leases manufacturing business to CMO

August 9, 2011
Manufacturing and Production Aenova, Skyepharma, pharma manufacturing news

German contract manufacturer Aenova is to lease a manufacturing unit near Lyon, France, from UK drugmaker SkyePharma. Aenova has taken …

News

AZ stops making Pulmicort pMDI inhaler

March 8, 2011
Manufacturing and Production AZ, AstraZeneca, Pulmicort, Pulmicort pMDI, Skyepharma, asthma, asthma inhaler, budesonide

AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …

News

SkyePharma filing Flutiform in Europe

March 26, 2010
Sales and Marketing Fluctiform, Skyepharma

SkyePharma is filing its asthma inhaler Flutiform with European regulatory authorities for approval. If approved Flutiform, a fluticasone and formoterol …

News

SkyePharma cuts staff at French and Swiss facilities

May 20, 2009
Research and Development, Sales and Marketing Skyepharma

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …

News

SkyePharma to cut back on manufacturing staff

March 11, 2009
Manufacturing and Production Europe, France, Skyepharma

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024